Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torben F Orntoft

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Nature Genetics|April 28, 2006
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibitionSantiago Ropero, Mario F Fraga, Esteban Ballestar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal CancerRobert N Jorissen, Peter Gibbs, Michael Christie, et al.
Thyroid : Official Journal of the American Thyroid Association|September 26, 2008
Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasmsYongchun Wang, Jeanne Kowalski, Hua-Ling Tsai, et al.
Molecular & Cellular Proteomics : MCP|March 21, 2008
Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysisKasper Thorsen, Karina D Sørensen, Anne Sofie Brems-Eskildsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancersRobert N Jorissen, Lara Lipton, Peter Gibbs, et al.
The Journal of Urology|January 4, 2017
FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter StudyWillemien Beukers, Kirstin A van der Keur, Raju Kandimalla, et al.
Nature|August 1, 2014
Putative cis-regulatory drivers in colorectal cancerHalit Ongen, Claus L Andersen, Jesper B Bramsen, et al.
Cancer Research|January 9, 2003
EXO1 variants occur commonly in normal population: evidence against a role in hereditary nonpolyposis colorectal cancerShantie Jagmohan-Changur, Taija Poikonen, Susa Vilkki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation studyLars Dyrskjøt, Karsten Zieger, Francisco X Real, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2014
External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohortLi-Mei Chen, Myron Chang, Yunfeng Dai, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Nature Genetics|April 28, 2006
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibitionSantiago Ropero, Mario F Fraga, Esteban Ballestar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal CancerRobert N Jorissen, Peter Gibbs, Michael Christie, et al.
Thyroid : Official Journal of the American Thyroid Association|September 26, 2008
Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasmsYongchun Wang, Jeanne Kowalski, Hua-Ling Tsai, et al.
Molecular & Cellular Proteomics : MCP|March 21, 2008
Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysisKasper Thorsen, Karina D Sørensen, Anne Sofie Brems-Eskildsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancersRobert N Jorissen, Lara Lipton, Peter Gibbs, et al.
The Journal of Urology|January 4, 2017
FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter StudyWillemien Beukers, Kirstin A van der Keur, Raju Kandimalla, et al.
Nature|August 1, 2014
Putative cis-regulatory drivers in colorectal cancerHalit Ongen, Claus L Andersen, Jesper B Bramsen, et al.
Cancer Research|January 9, 2003
EXO1 variants occur commonly in normal population: evidence against a role in hereditary nonpolyposis colorectal cancerShantie Jagmohan-Changur, Taija Poikonen, Susa Vilkki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation studyLars Dyrskjøt, Karsten Zieger, Francisco X Real, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2014
External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohortLi-Mei Chen, Myron Chang, Yunfeng Dai, et al.
Pageof 7